Sargent Bickham Lagudis’s PhenomeX Inc. Common Stock CELL Stock Holding History

Sargent Bickham Lagudis’s Portfolio CELL Stock Details CELL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$134	Hold	50	–	–	﹤0.01%	1021
2022 Q3	$0	Hold	50	–	–	﹤0.01%	1155
2022 Q2	$0	Hold	50	–	–	﹤0.01%	1161
2022 Q1	$0	Hold	50	–	–	﹤0.01%	1040
2021 Q4	$1K	Hold	50	–	–	﹤0.01%	944
2021 Q3	$1K	Hold	50	–	–	﹤0.01%	934
2021 Q2	$2K	Hold	50	–	–	﹤0.01%	878
2021 Q1	$3K	Hold	50	–	–	﹤0.01%	848
2020 Q4	$4K	Hold	50	–	–	﹤0.01%	769
2020 Q3	$4K	Buy	+50	New	+$3.17K	﹤0.01%	688

Other funds holding CELL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NIMC

Nierenberg Investment Management Company Camas, Washington $201M AUM 36.3% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sargent Bickham Lagudis's CELL Position: Q4 2022 in Review

Sargent Bickham Lagudis held its PhenomeX Inc. Common Stock (CELL) position steady in Q4 2022 at 50 shares worth $134. The position accounts for ﹤0.01% of the portfolio, ranked #1021.

Sargent Bickham Lagudis first reported a position in CELL in Q3 2020 and has held it in 10 quarters since. The position peaked at $4K in Q4 2020. 117 funds tracked by Wall St. Rank hold CELL as of Q4 2022.

Sargent Bickham Lagudis held 50 shares of PhenomeX Inc. Common Stock worth $134 as of Q4 2022.
Sargent Bickham Lagudis left its PhenomeX Inc. Common Stock share count unchanged in Q4 2022.
PhenomeX Inc. Common Stock made up ﹤0.01% of Sargent Bickham Lagudis's portfolio in Q4 2022, its #1021 holding.
Sargent Bickham Lagudis first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and has held it in 10 quarters since.
Sargent Bickham Lagudis's PhenomeX Inc. Common Stock position peaked at $4K in Q4 2020.
117 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q4 2022, filed 23 Jan 2023.